Pfizer will combine its off-patent drug business with Mylan
July 29, 2019 at 06:46 AM EDT
The deal will result in Pfizer shareholders owning most of the new company with Mylan's shareholders owning slightly more than 40%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|